Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PinnacleXon Dec 02, 2022 11:25am
152 Views
Post# 35146464

RE:RE:Lost it all

RE:RE:Lost it all
SS1316 wrote: Firstly I sincerely hope your mention of being 'suicidal' is no more than dark humor, your life is of more value than any capital returns could ever amount to. I'm a professional FF myself,  just a regular joe gettting beat down in the market this year and my position in THTX is down close to -30k but I intend to hold firm. This is not over IMO. Something about those 2 companies initiating coverage right before this news has me thinking there's more going on here than the short info we were just slapped in the mouth with... 


No Humor here my friend, but Im down way more then this, I have other stocks, I have almost nothing left maybe 1700 bucks.  Mortgage payment. 

As for your other mention, only thing that makes money for the company is 2 legacy drugs that are worth about 90 cents, so the SP is still very overpriced the stock is worth about 90 to 95 cents. 
<< Previous
Bullboard Posts
Next >>